DENTSPLY SIRONA Inc. (XRAY) stock
Close on Nov 11, 2026Market cap $1.95BP/E –Yield 6.56%
DENTSPLY SIRONA Inc. saw revenue fall 1.4% to $3.58B over the twelve months to Sep 30, 2026. Free cash flow was $103.00M, up 28.8% from a year earlier. At the latest close the market valued the company at $1.95B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $1.95B
- P/E ratio
- –
- Price to sales
- 0.54
- Price to book
- 1.44
- Dividend yield
- 6.56%
- Free cash flow yield
- 5.29%
Fundamentals
- Revenue
- $3.58B
- Net income
- -$121.00M
- EPS, diluted
- -$0.61
- Free cash flow
- $103.00M
- Book value per share
- $6.80
- Diluted shares
- 199M
Trading
- Next earnings
- Feb 25, 2027 (estimated, after the close)
- Previous close
- $9.70
- Open
- $9.54
- Day's range
- $9.37 – $9.85
- Volume
- 5,989,227
- Average volume (20 days)
- 5,159,370
- Index membership
- S&P MidCap 400 (since May 2024), Russell 2000 (since Jun 2026), Russell 3000
- Beta (5 years)
- 0.89
- 52-week range
- $8.13 – $14.76
- RSI (14 days)
- 53.5
- Volatility (1 year)
- 47.9%
- Relative volume
- 1.25×
- WACC
- 6.4%
Index membership is inferred from the holdings of funds that track each index (IJH, SPMD, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2009, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | XRAY | S&P 500 | Difference | XRAY per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +10.5% | -2.4% | +12.9 pts | ||
| 3 months | -15.9% | -1.2% | −14.8 pts | ||
| Year to date | -14.6% | +12.3% | −26.9 pts | ||
| 1 year | -9.8% | +12.4% | −22.3 pts | ||
| 3 years | -62.9% | +78.8% | −141.7 pts | -28.1% | +21.4% |
| 5 years | -80.1% | +75.2% | −155.3 pts | -27.6% | +11.9% |
| 10 years | -81.3% | +311.1% | −392.4 pts | -15.4% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Dentsply Sirona filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Results
- Results
About Dentsply Sirona
Dental Equipment & Supplies
Dentsply Sirona designs, manufactures, and distributes dental products, technologies, and healthcare consumable items. Its operations are divided into four reportable segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment, imaging systems, CAD/CAM technologies, treatment centers, restorative materials, endodontic tools, dental implants, clear aligners, and urological and enterological continence care medical devices. Additionally, it provides a cloud-based software platform to support digital clinical workflows. Its offerings serve dental practitioners, specialists, dental laboratories, medical providers, and patients.
Company profile, executives and historyDentsply Sirona stock: common questions
What is Dentsply Sirona's stock price?
XRAY closed at $9.76 on Nov 11, 2026, up 0.62% on the day. Over the past 52 weeks it traded between $8.13 and $14.76.
What is Dentsply Sirona's market cap?
Dentsply Sirona was worth $1.95B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is XRAY's P/E ratio?
Dentsply Sirona lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.61), so it has no meaningful P/E ratio.
How much revenue does Dentsply Sirona make?
Dentsply Sirona reported revenue of $3.58B for the twelve months to Sep 30, 2026, down 1.4% from a year earlier.
Does Dentsply Sirona pay a dividend?
Yes. Dentsply Sirona paid $0.64 per share over the last twelve months, a yield of 6.56% at the latest price.
When does Dentsply Sirona report earnings next?
Dentsply Sirona is expected to report Q4 FY2026 results on Feb 25, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has XRAY stock performed over the past year?
Including dividends, XRAY returned -9.8% over the past year, against +12.4% for the S&P 500.
How many XRAY shares are sold short?
26M shares were sold short at the latest FINRA report, 13.24% of the float, or 6.4 days of average trading volume.
Who are Dentsply Sirona's competitors?
Companies most similar to Dentsply Sirona by business, industry and size include NVST, ALGN, SOLV, TFX, RMD.
See a number that looks wrong?